Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Subject Demography.

From: The inhaled phosphodiesterase 4 inhibitor GSK256066 reduces allergen challenge responses in asthma

Variable Value
Age/years 31 (20 - 46)
Gender (Male/Female) 13/11
FEV1 % predicted 90.1 (71.3 - 111.8)
Allergen used for bronchial challenge 14 dust mite, 5 cat dander, 5 grass mix
  1. Mean (range) shown for age and FEV1.